Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Erik Oleson to Cannabinoids

This is a "connection" page, showing publications Erik Oleson has written about Cannabinoids.

 
Connection Strength
 
 
 
1.390
 
  1. Oleson EB, Khokhar JY. Cannabinoids: Emerging developments in neuropsychopharmacology and biological psychiatry. Prog Neuropsychopharmacol Biol Psychiatry. 2021 08 30; 110:110305.
    View in: PubMed
    Score: 0.658
  2. Gomez DM, Everett TJ, Hamilton LR, Ranganath A, Cheer JF, Oleson EB. Chronic cannabinoid exposure produces tolerance to the dopamine releasing effects of WIN 55,212-2 and heroin in adult male rats. Neuropharmacology. 2021 01; 182:108374.
    View in: PubMed
    Score: 0.641
  3. Loewinger GC, Oleson EB, Cheer JF. Using dopamine research to generate rational cannabinoid drug policy. Drug Test Anal. 2013 Jan; 5(1):22-6.
    View in: PubMed
    Score: 0.091
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)